77 related articles for article (PubMed ID: 9400021)
21. The role of cyclic-AMP on arginase activity by a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans.
Sosroseno W; Musa M; Ravichandran M; Fikri Ibrahim M; Bird PS; Seymour GJ
Oral Microbiol Immunol; 2006 Dec; 21(6):347-52. PubMed ID: 17064391
[TBL] [Abstract][Full Text] [Related]
22. Role of phosphodiesterases in the regulation of endothelial permeability in vitro.
Suttorp N; Weber U; Welsch T; Schudt C
J Clin Invest; 1993 Apr; 91(4):1421-8. PubMed ID: 8386187
[TBL] [Abstract][Full Text] [Related]
23. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
24. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS
Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
[TBL] [Abstract][Full Text] [Related]
25. Bronchial vs. cardiovascular activities of selective phosphodiesterase inhibitors in the anesthetized beta-blocked dog.
Heaslip RJ; Buckley SK; Sickels BD; Grimes D
J Pharmacol Exp Ther; 1991 May; 257(2):741-7. PubMed ID: 2033517
[TBL] [Abstract][Full Text] [Related]
26. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart.
Bian JS; Zhang WM; Pei JM; Wong TM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1065-70. PubMed ID: 10688624
[TBL] [Abstract][Full Text] [Related]
27. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
Marko D; Romanakis K; Zankl H; Fürstenberger G; Steinbauer B; Eisenbrand G
Cell Biochem Biophys; 1998; 28(2-3):75-101. PubMed ID: 9515161
[TBL] [Abstract][Full Text] [Related]
28. Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors.
Uckert S; Bazrafshan S; Scheller F; Mayer ME; Jonas U; Stief CG
Urology; 2007 Jul; 70(1):185-9. PubMed ID: 17656245
[TBL] [Abstract][Full Text] [Related]
29. Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai.
Schudt C; Winder S; Forderkunz S; Hatzelmann A; Ullrich V
Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):682-90. PubMed ID: 1663589
[TBL] [Abstract][Full Text] [Related]
30. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of specific phosphodiesterase isoenzyme inhibitors on bovine oocyte meiotic maturation.
Thomas RE; Armstrong DT; Gilchrist RB
Dev Biol; 2002 Apr; 244(2):215-25. PubMed ID: 11944932
[TBL] [Abstract][Full Text] [Related]
32. Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice.
Fischer W; Schudt C; Wendel A
Biochem Pharmacol; 1993 Jun; 45(12):2399-404. PubMed ID: 8392340
[TBL] [Abstract][Full Text] [Related]
33. [Rolipram reversed salbutamol tolerance in guinea pig trachea].
Chen JQ; Lu YB; Zhou HL
Yao Xue Xue Bao; 1997 Apr; 32(4):255-8. PubMed ID: 11499026
[TBL] [Abstract][Full Text] [Related]
34. Zardaverine as a selective inhibitor of phosphodiesterase isozymes.
Schudt C; Winder S; Müller B; Ukena D
Biochem Pharmacol; 1991 Jun; 42(1):153-62. PubMed ID: 1648920
[TBL] [Abstract][Full Text] [Related]
35. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
Maurice DH
Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
[TBL] [Abstract][Full Text] [Related]
36. Elevation of intracellular cAMP evokes activity-dependent release of adenosine in cultured rat forebrain neurons.
Lu Y; Li Y; Herin GA; Aizenman E; Epstein PM; Rosenberg PA
Eur J Neurosci; 2004 May; 19(10):2669-81. PubMed ID: 15147301
[TBL] [Abstract][Full Text] [Related]
37. Novel phosphodiesterase 4 inhibitor T-440 reverses and prevents human bronchial contraction induced by allergen.
Fujii K; Kohrogi H; Iwagoe H; Hamamoto J; Hirata N; Goto E; Kawano O; Wada K; Yamagata S; Ando M
J Pharmacol Exp Ther; 1998 Jan; 284(1):162-9. PubMed ID: 9435174
[TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors.
Oger S; Méhats C; Barnette MS; Ferré F; Cabrol D; Leroy MJ
Biol Reprod; 2004 Feb; 70(2):458-64. PubMed ID: 14561639
[TBL] [Abstract][Full Text] [Related]
39. Effects of rolipram, a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharide-induced uveitis in rats.
Chi ZL; Hayasaka S; Zhang XY; Hayasaka Y; Cui HS
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2497-502. PubMed ID: 15277469
[TBL] [Abstract][Full Text] [Related]
40. Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung.
Gonçalves de Moraes VL; Singer M; Vargaftig BB; Chignard M
Br J Pharmacol; 1998 Feb; 123(4):631-6. PubMed ID: 9517381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
